DETERMINATION OF S-100 AND GLIAL FIBRILLARY ACIDIC PROTEIN CONCENTRATIONS IN CEREBROSPINAL-FLUID AFTER BRAIN INFARCTION

Background and Purpose: We initiated the present study to evaluate the clinical value of consecutive concentration determinations of S-100 and glial fibrillary acidic proteins in cerebrospinal fluid from patients with brain infarction. Methods: We took sequential samples of cerebrospinal fluid from 28 patients within 48 hours, at 7 days, and at 18-21 days after the ictus. We measured astroglial protein concentrations using an enzyme-linked immunosorbent assay and also determined size of the infarction (computed tomography), clinical state of the patient (simplified activities of daily living test), blood-brain barrier dysfunction (cerebrospinal fluid/serum albumin ratio), and a myelin marker (myelin basic protein). Results: We found a transient increase of both proteins in the cerebrospinal fluid during the first week after the ischemic stroke (p < 0.05). This increment was significantly correlated with the size of the infarction and the clinical state of the patients. Conclusions: Transient release of astroglial proteins into the cerebrospinal fluid possibly reflects initial focal ischemic damage and, in the later phase, ongoing destruction of astroglial cells in the penumbra zone. We suggest that determinations of cerebrospinal fluid astroglial protein concentrations can be used to estimate ischemic brain damage, which should be of particular value in clinical trials of pharmacological agents, such as calcium antagonists, on stroke patients.